Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Eptifibatide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 208,866Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of June 26, 2024
    Enforcement Report - Week of June 26, 2024

    26 Jun 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-26-2024-3489.pdf

    FDA
    26 Jun 2024
    Share Share
    Avenacy Announces Launch of Eptifibatide for Injection in the U.S. Market
    Avenacy Announces Launch of Eptifibatide for Injection in the U.S. Market

    29 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240429526438/en

    BUSINESSWIRE
    29 Apr 2024
    Share Share
    Shuangcheng's Generic Eptifibatide receives Approval in the US
    Shuangcheng's Generic Eptifibatide receives Approval in the US

    07 Sep 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213081

    FDA
    07 Sep 2021
    Share Share
    Hybio's Generic Eptifibatide Receive Approval in U.S
    Hybio's Generic Eptifibatide Receive Approval in U.S

    30 Mar 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210089

    FDA
    30 Mar 2020
    Share Share
    Enforcement Report - Week of September 4, 2019
    Enforcement Report - Week of September 4, 2019

    04 Sep 2019

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-4-2019-1567563406.pdf

    FDA
    04 Sep 2019
    Share Share
    Baxter International Nabs FDA Approval for Insulin IV Infusion
    Baxter International Nabs FDA Approval for Insulin IV Infusion

    23 Jul 2019

    // Alex Keown BIOSPACE

    https://www.biospace.com/article/baxter-international-nabs-fda-approval-for-insulin-iv-infusion-myxredlin/

    Alex Keown BIOSPACE
    23 Jul 2019
    Share Share